Stay updated on Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Sign up to get notified when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision: v3.6.5 added in the footer, replacing v3.6.4. This reflects a minor site update and does not change the study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-08-08T22:50:58.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T12:36:13.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision line now reads Revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor version bump in the page revision history without altering study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:49.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing v3.6.0. This indicates a software update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-26T22:31:40.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants' and new guidance links were added to help readers understand and join the study. A formatting adjustment for the Intervention/Treatment header and a revision notice update from v3.5.5 to v3.6.0 are also reflected.
    Difference
    0.4%
    Check dated 2026-06-12T16:15:49.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added and Revision: v3.5.4 was removed, signaling an update to the ClinicalTrials.gov record. The change represents an update to the page's version metadata rather than substantive changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-05T11:59:24.000Z thumbnail image

Stay in the know with updates to Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.